High levels of fatty acids increase contractile function of neonatal rabbit hearts during reperfusion following ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 5, 2010, Pages

  Ito, Masayoshi ^a   Jaswal, Jagdip S ^a   Lam, Victoria H ^a   Oka, Tatsujiro ^a   Zhang, Liyan ^a   Beker, Donna L ^a   Lopaschuk, Gary D ^a   Rebeyka, Ivan M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiac efficiency; Cardioprotection; Fatty acid metabolism; Glucose metabolism

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCOSE; PALMITIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRY WEIGHT; ENERGY EXPENDITURE; FATTY ACID METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE; ISOLATED HEART; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION;

3-HYDROXYACYL COA DEHYDROGENASES; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CARBOXY-LYASES; CITRATE (SI)-SYNTHASE; ENERGY METABOLISM; FATTY ACIDS; FEMALE; GLUCOSE; GLYCOLYSIS; KINETICS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; OXIDATION-REDUCTION; PALMITIC ACID; PERFUSION; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; VENTRICULAR FUNCTION, LEFT;

EID: 77951819987     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00284.2009     Document Type: Article

References (73)

1. Allen BS. The clinical significance of the reoxygenation injury in pediatric heart surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 6: 116-127, 2003.
2. Allen BS. Pediatric myocardial protection: a cardioplegic strategy is the "solution." Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 7: 141-154, 2004.
3. Allen BS. Pediatric myocardial protection: where do we stand? J Thorac Cardiovasc Surg 128: 11-13, 2004.
4. Allen BS, Barth MJ, Ilbawi MN. Pediatric myocardial protection: an overview. Semin Thorac Cardiovasc Surg 13: 56-72, 2001.
5. Amark K, Berggren H, Bjork K, Ekroth A, Ekroth R, Nilsson K, Sunnegardh J. Blood cardioplegia provides superior protection in infant cardiac surgery. Ann Thorac Surg 80: 989-994, 2005. (Pubitemid 41196800)
6. Barr RL, Lopaschuk GD. Direct measurement of energy metabolism in the isolated working rat heart. J Pharmacol Toxicol Methods 38: 11-17, 1997. (Pubitemid 27460595)
7. Bartelds B, Gratama JW, Knoester H, Takens J, Smid GB, Aarnoudse JG, Heymans HS, Kuipers JR. Perinatal changes in myocardial supply and flux of fatty acids, carbohydrates, and ketone bodies in lambs. Am J Physiol Heart Circ Physiol 274: H1962-H1969, 1998. (Pubitemid 28308816)
8. Bartelds B, Knoester H, Beaufort-Krol GC, Smid GB, Takens J, Zijlstra WG, Heymans HS, Kuipers JR. Myocardial lactate metabolism in fetal and newborn lambs. Circulation 99: 1892-1897, 1999.
9. Bartelds B, Knoester H, Smid GB, Takens J, Visser GH, Penninga L, van der Leij FR, Beaufort-Krol GC, Zijlstra WG, Heymans HS, Kuipers JR. Perinatal changes in myocardial metabolism in lambs. Circulation 102: 926-931, 2000.
10. Boucek RJ Jr, Miracle A, Anderson M, Engelman R, Atkinson J, Dodd DA. Persistent effects of doxorubicin on cardiac gene expression. J Mol Cell Cardiol 31: 1435-1446, 1999. (Pubitemid 29361111)
11. Boucek RJ Jr, Shelton ME, Artman M, Landon E. Myocellular calcium regulation by the sarcolemmal membrane in the adult and immature rabbit heart. Basic Res Cardiol 80: 316-325, 1985. (Pubitemid 15015989)
12. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223, 2007.
13. Boudina S, Abel ED. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 21: 250-258, 2006.
14. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56: 2457-2466, 2007.
15. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146: 5341-5349, 2005.
16. 2+ overload and left ventricular mechanical dysfunction. J Cardiovasc Electrophysiol 17, Suppl 1: S141-S148, 2006.
17. Collins-Nakai RL, Noseworthy D, Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol Heart Circ Physiol 267: H1862-H1871, 1994. (Pubitemid 2164399)
18. Durandy Y. Pediatric myocardial protection. Curr Opin Cardiol 23: 85-90, 2008.
19. Dyck JR, Barr AJ, Barr RL, Kolattukudy PE, Lopaschuk GD. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol Heart Circ Physiol 275: H2122-H2129, 1998. (Pubitemid 128731581)
20. Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, Wallace D, Arrhenius T, Harmon C, Yang G, Nadzan AM, Lopaschuk GD. Malonyl coenzyme A decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circ Res 94: e78-e84, 2004.
21. Dyck JR, Hopkins TA, Bonnet S, Michelakis ED, Young ME, Watanabe M, Kawase Y, Jishage K, Lopaschuk GD. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation 114: 1721-1728, 2006. (Pubitemid 44607120)
22. Forster K, Kuno A, Solenkova N, Felix SB, Krieg T. The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol 293: H1604-H1608, 2007. (Pubitemid 47367206)
23. 2+-dependent proteolysis? Circ Res 78: 455-465, 1996.
24. Hammon JW Jr. Myocardial protection in the immature heart. Ann Thorac Surg 60: 839-842, 1995.
25. 2+ cycling in isolated failing human myocardium. Circulation 105: 194-199, 2002.
26. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288: H971-H976, 2005. (Pubitemid 40139686)
27. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460, 2004.
28. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116: 173-191, 2007.
29. How OJ, Aasum E, Kunnathu S, Severson DL, Myhre ES, Larsen TS. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts. Am J Physiol Heart Circ Physiol 288: H2979-H2985, 2005. (Pubitemid 40720683)
30. 2 framework. Acta Physiol (Oxf) 190: 171-175, 2007.
31. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55: 466-473, 2006. (Pubitemid 43343277)
32. Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, Moore PK, Bian JS. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflügers Arch 455: 607-616, 2008. (Pubitemid 350160475)
33. Hutter JF, Piper HM, Spieckerman PG. Effect of fatty acid oxidation on efficiency of energy production in rat heart. Am J Physiol Heart Circ Physiol 249: H723-H728, 1985. (Pubitemid 16207212)
34. 2+ exchanger confers protection against ischemia/reperfusion injury. Circ Res 97: 916-921, 2005.
35. Itoi T, Huang L, Lopaschuk GD. Glucose use in neonatal rabbit hearts reperfused after global ischemia. Am J Physiol Heart Circ Physiol 265: H427-H433, 1993. (Pubitemid 23273574)
36. Itoi T, Lopaschuk GD. Calcium improves mechanical function and carbohydrate metabolism following ischemia in isolated bi-ventricular working hearts from immature rabbits. J Mol Cell Cardiol 28: 1501-1514, 1996. (Pubitemid 26340904)
37. Itoi T, Lopaschuk GD. The contribution of glycolysis, glucose oxidation, lactate oxidation, and fatty acid oxidation to ATP production in isolated biventricular working hearts from 2-week-old rabbits. Pediatr Res 34: 735-741, 1993. (Pubitemid 23352638)
38. Jaswal JS, Gandhi M, Finegan BA, Dyck JR, Clanachan AS. Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization. Am J Physiol Heart Circ Physiol 293: H1107-H1114, 2007. (Pubitemid 47254211)
39. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 86: 580-588, 2000. (Pubitemid 30165050)
40. 31P NMR analyses. Am J Physiol Heart Circ Physiol 258: H1357-H1365, 1990.
41. Lewandowski ED, White LT. Pyruvate dehydrogenase influences postischemic heart function. Circulation 91: 2071-2079, 1995.
42. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 79: 940-948, 1996. (Pubitemid 26359235)
43. Liu B, el Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. Am J Physiol Heart Circ Physiol 270: H72-H80, 1996. (Pubitemid 26065108)
44. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 39: 718-725, 2002. (Pubitemid 34158171)
45. Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 93: e33-e37, 2003.
46. Lopaschuk GD, Collins-Nakai R, Olley PM, Montague TJ, McNeil G, Gayle M, Penkoske P, Finegan BA. Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 128: 61-67, 1994. (Pubitemid 24227136)
47. Lopaschuk GD, Saddik M. The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol Cell Biochem 116: 111-116, 1992.
48. Lopaschuk GD, Spafford MA. Energy substrate utilization by isolated working hearts from newborn rabbits. Am J Physiol Heart Circ Physiol 258: H1274-H1280, 1990.
49. Lopaschuk GD, Spafford MA, Marsh DR. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am J Physiol Heart Circ Physiol 261: H1698-H1705, 1991.
50. Lopaschuk GD, Witters LA, Itoi T, Barr R, Barr A. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. J Biol Chem 269: 25871-25878, 1994. (Pubitemid 24336288)
51. Makinde AO, Gamble J, Lopaschuk GD. Upregulation of 5′-AMPactivated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res 80: 482-489, 1997. (Pubitemid 27137284)
52. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93: 135-142, 1996.
53. Medina JM. The role of lactate as an energy substrate for the brain during the early neonatal period. Biol Neonate 48: 237-244, 1985.
54. Molero JC, Waring SG, Cooper A, Turner N, Laybutt R, Cooney GJ, James DE. Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance. Diabetes 55: 708-715, 2006. (Pubitemid 43343227)
55. Mukherjee S, Lekli I, Das M, Azzi A, Das DK. Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 1782: 498-503, 2008.
56. Myrmel T, Forsdahl K, Larsen TS. Triacylglycerol metabolism in hypoxic, glucose-deprived rat cardiomyocytes. J Mol Cell Cardiol 24: 855-868, 1992.
57. Onay-Besikci A, Altarejos JY, Lopaschuk GD. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts. J Biol Chem 279: 44320-44326, 2004. (Pubitemid 39430836)
58. Onay-Besikci A, Campbell FM, Hopkins TA, Dyck JR, Lopaschuk GD. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart. Am J Physiol Heart Circ Physiol 284: H283-H289, 2003.
59. Parrish MD, Ayres NA, Kendrick BT, Fixler DE. Maturational differences in the isolated isovolumic rabbit heart. Am J Physiol Heart Circ Physiol 251: H1143-H1148, 1986.
60. Parrish MD, Payne A, Fixler DE. Global myocardial ischemia in the newborn, juvenile, and adult isolated isovolumic rabbit heart. Age-related differences in systolic function, diastolic stiffness, coronary resistance, myocardial oxygen consumption, and extracellular pH. Circ Res 61: 609-615, 1987. (Pubitemid 17157300)
61. Reid EA, Kristo G, Yoshimura Y, Ballard-Croft C, Keith BJ, Mentzer RM Jr, Lasley RD. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling. Am J Physiol Heart Circ Physiol 288: H2253-H2259, 2005. (Pubitemid 40604113)
62. Riva E, Hearse DJ. Isolated, perfused neonatal rat heart preparation for studies of calcium and functional stability. Ann Thorac Surg 52: 987-992, 1991.
63. Saiki Y, Lopaschuk GD, Dodge K, Yamaya K, Morgan C, Rebeyka IM. Pyruvate augments mechanical function via activation of the pyruvate dehydrogenase complex in reperfused ischemic immature rabbit hearts. J Surg Res 79: 164-169, 1998. (Pubitemid 28467353)
64. Soltys CL, Buchholz L, Gandhi M, Clanachan AS, Walsh K, Dyck JR. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol 283: H1056-H1064, 2002.
65. Stanley WC, Morgan EE, Huang H, McElfresh TA, Sterk JP, Okere IC, Chandler MP, Cheng J, Dyck JR, Lopaschuk GD. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. Am J Physiol Heart Circ Physiol 289: H2304-H2309, 2005. (Pubitemid 41698536)
66. Suga H. Ventricular energetics. Physiol Rev 70: 247-277, 1990.
67. Taniguchi M, Wilson C, Hunter CA, Pehowich DJ, Clanachan AS, Lopaschuk GD. Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. Am J Physiol Heart Circ Physiol 280: H1762-H1769, 2001. (Pubitemid 32466213)
68. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56: 2085-2092, 2007. (Pubitemid 47195821)
69. Vik-Mo H, Mjos OD. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am J Cardiol 48: 361-365, 1981. (Pubitemid 11019075)
70. Werner JC, Sicard RE. Lactate metabolism of isolated, perfused fetal, and newborn pig hearts. Pediatr Res 22: 552-556, 1987. (Pubitemid 18002062)
71. Werner JC, Whitman V, Fripp RR, Schuler HG, Musselman J, Sham RL. Fatty acid and glucose utilization in isolated, working fetal pig hearts. Am J Physiol Endocrinol Metab 245: E19-E23, 1983. (Pubitemid 13195601)
72. Yatscoff MA, Jaswal JS, Grant MR, Greenwood R, Lukat T, Beker DL, Rebeyka IM, Lopaschuk GD. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart. Pediatr Res 64: 643-647, 2008.
73. 2+ release in rats via mitochondria-dependent and -independent mechanisms. J Physiol 550: 765-783, 2003.